25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension – Is it worth the “Hype”?

Documenti analoghi

• The 25-hydroxyvitamin D(3) C-3 epimer: Distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC)
  di: Lutsey, Pamela L., et al.
  Pubblicazione: (2015)
• 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC Study
  di: Michos, Erin D., et al.
  Pubblicazione: (2015)
• 25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification
  di: de Boer, Ian H., et al.
  Pubblicazione: (2009)
• 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
  di: Michos, Erin D., et al.
  Pubblicazione: (2016)
• Factors Associated With Change in 25-Hydroxyvitamin D Levels Over Longitudinal Follow-Up in the ARIC Study
  di: McKibben, Rebeccah A., et al.
  Pubblicazione: (2016)